In this Issue:
Adalimumab and infliximab levels in neonates
Assessing primary non-response to infliximab in CD
Disease relapse in CD after anti-TNF withdrawal
Changes in UC faecal microbiota after FMT
Newly-diagnosed IBD in Australia: significant costs
Budesonide-MMX induces remission in active UC flares
Colonoscopic surveillance for UC detects CRC earlier
anti-TNFs safe in IBD with a history of cancer
Include methotrexate in UC disease management?
Curcumin shows promise in treatment of UC
Please login below to download this issue (PDF)